REQUEST A DEMO
Total
USD $0.00
Search more companies

Glaxosmithkline Asia Pvt.Ltd. (India)

Main Activities: Other Services (except Public Administration)
Full name: Glaxosmithkline Asia Pvt.Ltd. Profile Updated: February 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Glaxosmithkline Asia Pvt. Ltd. is a private limited company located in Patiala, Punjab. It was incorporated on October 18, 1995. The company is engaged in the production of prescription drugs, proprietary drugs, and toiletries. Its main products and services include vitamin tablets, paracetamol tablets and syrup, Combiflam, Sumo Cold Medicine, and Cetirizine tablets. Glaxosmithkline Asia Pvt. Ltd. aims to positively impact the health of 2.5 billion people by the end of 2030. The company has an authorized share capital of INR 10.00 crore and a paid-up capital of INR 5.50 crore. Its operating revenues for the financial year ending on March 31, 2022, were over INR 500 crore. The company's current status is active, and it has four directors. The Corporate Identification Number (CIN) of Glaxosmithkline Asia Pvt. Ltd. is U99999PB1995PTC028476.

Legal Address
Patiala Road, Nabha,
Patiala; Punjab; Postal Code: 147201

Contact Details: Purchase the Glaxosmithkline Asia Pvt.Ltd. report to view the information.

Website: http://www.gsk.com

Basic Information
Outstanding Shares:
Purchase the Glaxosmithkline Asia Pvt.Ltd. report to view the information.
Registered Capital:
Purchase the Glaxosmithkline Asia Pvt.Ltd. report to view the information.
Incorporation Date:
October 18, 1995
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Nominee Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Nominee Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Glaxosmithkline Asia Pvt.Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
15.09%
Total operating revenue
16.15%
Operating profit (EBIT)
6.75%
EBITDA
7.23%
Net Profit (Loss) for the Period
-7.99%
Total assets
23.92%
Total equity
20.96%
Operating Profit Margin (ROS)
-2.18%
Net Profit Margin
-5.18%
Return on Equity (ROE)
-5.46%
Quick Ratio
-2.28%
Cash Ratio
-2.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?